Clinical outcomes of early closure versus conservative strategy after diagnosis with atrial septal defect: a nationwide population-based cohort study

Eur J Cardiothorac Surg. 2022 Jul 11;62(2):ezac076. doi: 10.1093/ejcts/ezac076.

Abstract

Objectives: The long-term clinical benefits of atrial septal defect (ASD) closure remain controversial. We aimed to compare long-term clinical outcomes between patients who underwent early surgical closure after ASD diagnosis and those who did not.

Methods: Using the Korean National Health Insurance Service database, we identified patients with isolated ASDs diagnosed between 1 January 2003 and 31 December 2006. The ASD patients who underwent closure surgery within 6 months after diagnosis were allocated to the early-closure group and the rest were allocated to the conservative-strategy group. The primary outcome was all-cause mortality. Secondary outcomes were atrial flutter/fibrillation (AFF) and ischaemic stroke.

Results: Among patients without a history of AFF or stroke, 1644 patients in the early-closure group were propensity score matched to 1644 patients in the conservative-strategy group and their median follow-up durations were 12.9 and 12.8 years, respectively. The early closure was associated with a significantly lower risk of mortality (hazard ratio, 0.55 [95% confidence interval, 0.43-0.70]). In an age-stratified analysis, significant mortality reductions in the early-closure group were found in patients aged 40 years or older. The risk of AFF was significantly higher in the early-closure group, which might be mainly ascribed to postoperative transient AFF, while there was no difference in ischaemic stroke between the 2 groups.

Conclusions: Our data suggest that timely ASD closure without delay is necessary for ASD patients without previous history of clinical events, especially in patients aged 40 years or older.

Keywords: Atrial septal defect; Prognosis; Surgery.

MeSH terms

  • Atrial Fibrillation* / etiology
  • Brain Ischemia* / etiology
  • Cardiac Catheterization / adverse effects
  • Cohort Studies
  • Conservative Treatment
  • Heart Septal Defects, Atrial* / diagnosis
  • Heart Septal Defects, Atrial* / epidemiology
  • Heart Septal Defects, Atrial* / surgery
  • Humans
  • Ischemic Stroke*
  • Septal Occluder Device* / adverse effects
  • Stroke* / epidemiology
  • Stroke* / etiology
  • Treatment Outcome